| HIF1A-AS2 | osteosarcoma | RT-PCR, Western blotting, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31866584 | 2019 |
| HIF1A-AS2 | bladder cancer | qPCR, Western blot, RNAi, Other | H | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30216500 | 2019 |
| HIF1A-AS2 | triple negative breast cancer | qPCR, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 30635931 | 2019 |
| HIF1A-AS2 | bladder cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 27018306 | 2016 |
| HIF1A-AS2 | gastric cancer | qPCR etc. | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 25686741 | 2015 |
| HIF1A-AS2 | renal cancer | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 9923855 | 1999 |
| HIF1A-AS2 | colorectal cancer | qRT-PCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 29278853 | 2017 |
| HIF1A-AS2 | glioblastoma | RIP, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 27264189 | 2016 |
| HIF1A-AS2 | breast cancer | microarray, qPCR etc. | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 28248879 | 2017 |
| HIF1A-AS2 | breast cancer | qPCR, Immunohistochemistry etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 14580258 | 2003 |
| HIF1A-AS2 | breast cancer | microarray, qPCR, RNAi, Cell proliferation assay, Cell invasion assay etc. | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 26921339 | 2016 |
| HIF1A-AS2 | Gastric cancer | qRT-PCR;Western blot;luciferase assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 33555514 | 2021 |